http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1130569-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-57 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-22 |
filingDate | 1981-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1984-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dc30d9fee48aa86b28895e89bbd2c9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c94883baa723c4f78f1a805fa334f49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd182fb26430a799ec63c23742380e85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cde960389b57189009c2762d048ee88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a80fbd88bafe20e81845401fcb479b7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b8f7f46237df6c6f045e1058f44115c |
publicationDate | 1984-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | SU-1130569-A1 |
titleOfInvention | Derivatives of 7alpha-methoxycephalosporin or their sodium salts having antimicrobial effect |
abstract | I. Derivatives of 7cC-methoxycephalosporin of the common formulg AXIS, Rj 9 CH-CONH-Ns CK2-R, СООИ where R is an acetoxy group, tetrazole-5-ylthio group, substituted in. position 1 by methyl, ethyl-dimethylamiriethyl, carboxymedshtom or methoxycarboylmethyl, 1,3,4-thiadiazole -2-ylthio group, is free or substituted in n-position 5 by methyl or carboxymethyl, or 1,3,4-oxadiazol-2- Iltyogruppa, substituted at -5 position with carboxymethyl; R is a hydrogen atom or hydroxy group} R, is a hydrogen atom or methoxy group, Rb is a hydrogen atom or hydroxy, nitro, acetoxy, ethoxycarbonyloxy-CPC 2,2,2-trichloroethoxycarbonyloxy group; a hydrogen or chlorine atom; or He, benzyloxy, OXI, acetoxy, ethoxycarbonyloxy, 2.2-three and 10 e-toeroxycarbonyloxy; a hydrogen atom, methyl or R. hydroxy or acetoxy group, or their sodium salts, possessing antimicrobial i activity. W 2. Derivatives of 7 ° C-methoxycephalosporin of the formula according to claim 1, wherein R; j is 1-carboxymethyltetrazol-5-nlthio group, 5-carboxymeTP1-1, 3,4-thiadiazol-2-ylthiogroup or 5 carboxymethyl -1.3,4 - oxadiazol-2-ylthio00 group; RZ hydroxy group; Izab Q1 hydrogen atom; - hydroxy group, 4 5 O5. or their sodium salts with antimicrobial activity. 3.7 - D-2- |
priorityDate | 1980-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.